Programmed cell death in Parkinson's disease

Handbook of Clinical Neurology

Volumn 83, Issue , 2007, Pages 591-605

  Burke, Robert E ^a  

^a The College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649331705     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)83029-6     Document Type: Review

References (131)

1. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 (1998) 1322-1326
2. Anglade P., Vyas S., Javoy-Agid F., et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12 (1997) 25-31
3. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
4. Barde Y.A. Trophic factors and neuronal survival. Neuron 2 (1989) 1525-1534
5. Behrens A., Sibilia M., and Wagner E.F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21 (1999) 326-329
6. Boatright K.M., and Salvesen G.S. Mechanisms of caspase activation. Curr Opin Cell Biol 15 (2003) 725-731
7. Boka G., Anglade P., Wallach D., et al. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 172 (1994) 151-154
8. Burke R.E. Ontogenic cell death in the nigrostriatal system. Cell Tissue Res 318 (2004) 63-72
9. Chai J., Du C., Wu J.W., et al. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406 (2000) 855-862
10. Ciechanover A. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17 (1998) 7151-7160
11. Clarke P.G.H. Neuronal death in the development of the vertebrate nervous system. Trends Neurosci 8 (1985) 345-349
12. Clarke P.G.H. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 181 (1990) 195-213
13. Crocker S.J., Lamba W.R., Smith P.D., et al. c-Jun mediates axotomy-induced dopamine neuron death in vivo. Proc Natl Acad Sci USA 98 (2001) 13385-13390
14. Curtius H.C., Wolfensberger M., Steinmann B., et al. Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr 99 (1974) 529-540
15. Datta S.R., Katsov A., Hu L., et al. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6 (2000) 41-51
16. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
17. Donovan N., Becker E.B., Konishi Y., et al. JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J Biol Chem 277 (2002) 40944-40949
18. Ellis R.E., Yuan J., and Horvitz H.R. Mechanisms and functions of cell death. Annu Rev Cell Biol 7 (1991) 663-698
19. Ernst M. Ueber Untergang von Zellen wahrend der normalen Entwicklung bei Wirbeltieren. Zeitschr Anat u Entw gesch 79 (1926) 228-262
20. Ferger B., Leng A., Mura A., et al. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum. J Neurochem 89 (2004) 822-833
21. Ferrer I., Olive M., Blanco R., et al. Selective c-Jun overexpression is associated with ionizing radiation-induced apoptosis in the developing cerebellum of the rat. Mol Br Res 38 (1996) 91-100
22. Ferrer I., Olive M., Ribera J., et al. Naturally occurring (programmed) and radiation-induced apoptosis are associated with selective c-jun expression in the developing rat brain. Eur J Neurosci 8 (1996) 1286-1298
23. Fischer H., Koenig U., Eckhart L., et al. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 293 (2002) 722-726
24. Furuya T., Hayakawa H., Yamada M., et al. Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci 24 (2004) 1865-1872
25. Ganguly A., Oo T.F., Rzhetskaya M., et al. CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamine. J Neurochem 88 (2004) 469-480
26. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119 (1992) 493-501
27. Glucksmann A. Cell deaths in normal vertebrate ontogeny. Biol Rev 26 (1951) 59-86
28. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., et al. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21 (1995) 1465-1468
29. Hamburger V. History of the discovery of neuronal death in embryos. J Neurobiol 23 (1992) 1116-1123
30. Hamburger V., and Levi-Montalcini R. Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 111 (1949) 457-502
31. Hartmann A., Hunot S., Michel P.P., et al. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 97 (2000) 2875-2880
32. Hartmann A., Michel P.P., and Troadec J.D. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?. J Neurochem 76 (2001) 1785-1793
33. Hartmann A., Troadec J.D., Hunot S., et al. Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J Neurosci 21 (2001) 2247-2255
34. Hartmann A., Mouatt-Prigent A., Faucheux B.A., et al. FADD: a link between TNF family receptors and caspases in Parkinson's disease. Neurology 58 (2002) 308-310
35. Hassouna I., Wickert H., Zimmermann M., et al. Increase in bax expression in substantia-nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice. Neurosci Lett 204 (1996) 85-88
36. Hayley S., Crocker S.J., Smith P.D., et al. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 24 (2004) 2045-2053
37. He Y., Lee T., and Leong S.K. 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra. Brain Res 858 (2000) 163-166
38. Hengartner M.O., and Horvitz H.R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76 (1994) 665-676
39. Herdegen T., Claret F.X., Kallunki T., et al. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J Neurosci 18 (1998) 5124-5135
40. Hitomi J., Katayama T., Eguchi Y., et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J Cell Biol 165 (2004) 347-356
41. Holtz W.A., and O'Malley K.L. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 278 (2003) 19367-19377
42. Hunot S., Vila M., Teismann P., et al. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 101 (2004) 665-670
43. Imai Y., Soda M., and Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J Biol Chem 275 (2000) 35661-35664
44. Imai Y., Soda M., Inoue H., et al. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105 (2001) 891-902
45. Ishikawa A., and Tsuji S. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 47 (1996) 160-166
46. Jackson-Lewis V., Jakowec M., Burke R.E., et al. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4 (1995) 257-269
47. Jackson-Lewis V., Vila M., Djaldetti R., et al. Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol 424 (2000) 476-488
48. Janec E., and Burke R.E. Naturally occurring cell death during postnatal development of the substantia nigra of the rat. Mol Cell Neurosci 4 (1993) 30-35
49. Jenkins R., and Hunt S.P. Long-term increase in the levels of c-jun mRNA and jun protein-like immunoreactivity in motor and sensory neurons following axon damage. Neurosci Lett 129 (1991) 107-110
50. Jenkins R., O'Shea R., Thomas K.L., et al. c-jun expression in substantia nigra neurons following striatal 6-hydroxydopamine lesions in the rat. Neuroscience 53 (1993) 447-455
51. Jeon B.S., Jackson-Lewis V., and Burke R.E. 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration 4 (1995) 131-137
52. Jeon B.S., Kholodilov N.G., Oo T.F., et al. Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J Neurochem 73 (1999) 322-333
53. Kane D.J., Sarafian T.A., Anton R., et al. Bcl 2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262 (1993) 1274-1277
54. Kerr J.F.R., Gobe G.C., Winterford C.M., et al. Anatomical methods in cell death. In: Schwartz L.M., and Osborne B.A. (Eds). Methods in Cell Biology: Cell Death (1995), Academic Press, New York 1-27
55. Kerr J.F.R., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
56. Kitada T., Asakawa S., Hattori N., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998) 605-608
57. Klionsky D.J., and Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 290 (2000) 1717-1721
58. Kosel S., Egensperger R., von Eitzen U., et al. On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropath 93 (1997) 105-108
59. Kostrzewa R.M., and Jacobowitz D.M. Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev 26 (1974) 199-288
60. Kothakota S., Azuma T., Reinhard C., et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278 (1997) 294-298
61. Kuma A., Hatano M., Matsui M., et al. The role of autophagy during the early neonatal starvation period. Nature 432 (2004) 1032-1036
62. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81 (2001) 807-869
63. Larsen K.E., Fon E.A., Hastings T.G., et al. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J Neurosci 22 (2002) 8951-8960
64. Leah J.D., Herdegen T., Murashov A., et al. Expression of immediate early gene proteins following axotomy and inhibition of axonal transport in the rat central nervous system. Neuroscience 57 (1993) 53-66
65. Lei K., and Davis R.J. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 100 (2003) 2432-2437
66. Levi-Montalcini R. The nerve growth factor 35 years later. Science 237 (1987) 1154-1162
67. Lum J.J., Bauer D.E., Kong M., et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120 (2005) 237-248
68. Marciniak S.J., Yun C.Y., Oyadomari S., et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18 (2004) 3066-3077
69. Marti M.J., James C.J., Oo T.F., et al. Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J Neurosci 17 (1997) 2030-2039
70. Marti M.J., Saura J., Burke R.E., et al. Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat. Brain Res 958 (2002) 185-191
71. Martin D.P., Schmidt R.E., DiStefano P., et al. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 106 (1988) 829-844
72. Merry D.E., and Korsmeyer S.J. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 20 (1997) 245-267
73. Messina A., Jaworowski A., and Bell C. Detection of jun but not fos protein during developmental cell death in sympathetic neurons. J Comp Neurol 372 (1996) 544-550
74. Mizushima N., Yoshimori T., and Ohsumi Y. Role of the Apg12 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 35 (2003) 553-561
75. Mochizuki H., Goto K., Mori H., et al. Histochemical detection of apoptosis in Parkinson's Disease. J Neurol Sci 137 (1996) 120-123
76. Mochizuki H., Hayakawa H., Migita M., et al. An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease. Proc Natl Acad Sci USA 98 (2001) 10918-10923
77. Mogi M., Harada M., Kondo T., et al. The soluble form of Fas molecule is elevated in parkinsonian brain tissues. Neurosci Lett 220 (1996) 195-198
78. Mogi M., Harada M., Riederer P., et al. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165 (1994) 208-210
79. Momoi T. Caspases involved in ER stress-mediated cell death. J Chem Neuroanat 28 (2004) 101-105
80. Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101 (2000) 451-454
81. Murakata C., Kaneko M., Gessner G., et al. Mixed lineage kinase activity of indolocarbazole analogues. Bioorg Med Chem Lett 12 (2002) 147-150
82. Nakagawa T., Zhu H., Morishima N., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 (2000) 98-103
83. Offen D., Beart P.M., Cheung N.S., et al. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc Natl Acad Sci USA 95 (1998) 5789-5794
84. Oo T.F., Blazeski R., Harrison S.M.W., et al. Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic. J Neurosci 16 (1996) 6134-6145
85. Oo T.F., and Burke R.E. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Dev Brain Res 98 (1997) 191-196
86. Oo T.F., Henchcliffe C., James D., et al. Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra. J Neurochem 72 (1999) 557-564
87. Oo T.F., Siman R., and Burke R.E. Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra. Exp Neurol 175 (2002) 1-9
88. Oppenheim R.W., Prevette D., Tytell M., et al. Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes. Dev Biol 138 (1990) 104-113
89. Putcha G.V., and Johnson Jr. E.M. Men are but worms: neuronal cell death in C. elegans and vertebrates. Cell Death Differ 11 (2004) 38-48
90. Putcha G.V., Moulder K.L., Golden J.P., et al. Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron 29 (2001) 615-628
91. Rao R.V., Hermel E., Castro-Obregon S., et al. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem 276 (2001) 33869-33874
92. Riedl S.J., and Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5 (2004) 897-907
93. Rukenstein A., Rydel R.E., and Greene L.A. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J Neurosci 11 (1991) 2552-2563
94. Ryu E.J., Harding H.P., Angelastro J.M., et al. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci 22 (2002) 10690-10698
95. Saporito M.S., Brown E.M., Miller M.S., et al. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J Pharmacol Exp Ther 288 (1999) 421-427
96. Saporito M.S., Thomas B.A., and Scott R.W. MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J Neurochem 75 (2000) 1200-1208
97. Sauer H., and Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6 hydroxydopamine a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59 (1994) 401-415
98. Scorrano L., and Korsmeyer S.J. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304 (2003) 437-444
99. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9 (2002) 459-470
100. Shimura H., Hattori N., Kubo S., et al. Familial parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25 (2000) 302-305
101. Shintani T., and Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 306 (2004) 990-995
102. Silva R.M., Kuan C.Y., Rakic P., et al. Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease. Mov Disord 20 6 (2005) 653-664
103. Silva R.M., Ries V., Oo T.F., et al. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J Neurochem 95 4 (2005) 974-986
104. + channels. Neuron 16 (1996) 321-331
105. Stefanis L., Larsen K.E., Rideout H.J., et al. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 21 (2001) 9549-9560
106. Strasser A., O'Connor L., and Dixit V.M. Apoptosis signaling. Annu Rev Biochem 69 (2000) 217-245
107. Susin S.A., Lorenzo H.K., Zamzami N., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (1999) 441-446
108. Tatton N.A. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol 166 (2000) 29-43
109. Tatton N.A., and Kish S.J. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange. Neuroscience 77 (1997) 1037-1048
110. Tatton N.A., Maclean-Fraser A., Tatton W.G., et al. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann Neurol 44 (1998) S142-S148
111. Teismann P., Tieu K., Choi D.K., et al. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci USA 100 (2003) 5473-5478
112. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
113. Tompkins M.M., Basgall E.J., Zamrini E., et al. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am J Path 150 (1997) 119-131
114. Turmel H., Hartmann A., Parain K., et al. Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Mov Disord 16 (2001) 185-189
115. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5 (1968) 107-110
116. Vaux D.L., Cory S., and Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335 (1988) 440-442
117. Vaux D.L., Weissman I.L., and Kim S.K. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258 (1992) 1955-1957
118. Vila M., Jackson-Lewis V., Vukosavic S., et al. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proc Natl Acad Sci USA 98 (2001) 2837-2842
119. Viswanath V., Wu Y., Boonplueang R., et al. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J Neurosci 21 (2001) 9519-9528
120. Wang L.H., Besirli C.G., and Johnson Jr. E.M. Mixed-lineage kinases: a target for the prevention of neurodegeneration. Annu Rev Pharmacol Toxicol 44 (2004) 451-474
121. Wei M.C., Zong W.X., Cheng E.H., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292 (2001) 727-730
122. White K., Grether M.E., Abrams J.M., et al. Genetic control of programmed cell death in Drosophila. Science 264 (1994) 677-683
123. Whitfield J., Neame S.J., Paquet L., et al. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 29 (2001) 629-643
124. Wullner U., Kornhuber J., Weller M., et al. Cell death and apoptosis regulating proteins in Parkinson's disease-a cautionary note. Acta Neuropathol (Berl) 97 (1999) 408-412
125. Xia X.G., Harding T., Weller M., et al. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 98 (2001) 10433-10438
126. Yang D.D., Kuan C.Y., Whitmarsh A.J., et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 (1997) 865-870
127. Yang L., Matthews R.T., Schulz J.B., et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J Neurosci 18 (1998) 8145-8152
128. Yu S.W., Wang H., Poitras M.F., et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297 (2002) 259-263
129. Yuan J., Shaham S., Ledoux S., et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75 (1993) 641-652
130. Zinszner H., Kuroda M., Wang X., et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12 (1998) 982-995
131. Zuch C.L., Nordstroem V.K., Briedrick L.A., et al. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion. J Comp Neurol 427 (2000) 440-454